/
Pathophysiology of retinal vein occlusion Pathophysiology of retinal vein occlusion

Pathophysiology of retinal vein occlusion - PowerPoint Presentation

debby-jeon
debby-jeon . @debby-jeon
Follow
478 views
Uploaded On 2017-06-26

Pathophysiology of retinal vein occlusion - PPT Presentation

Hamid Fesharaki MD Eye department Isfahan University of medical sciences In the name of god Types of retinal venous occlusion Central retinal vein occlusion Branch retinal vein occlusion Hemi retinal vein occlusion ID: 563738

crvo retinal occlusion vein retinal crvo vein occlusion ischemic central vegf patients edema blood capillary systemic brvo protein visual

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Pathophysiology of retinal vein occlusio..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Pathophysiology of retinal vein occlusion Hamid Fesharaki MD Eye department Isfahan University of medical sciences

In the name of godSlide2
Slide3
Slide4
Slide5
Slide6
Slide7
Slide8

Types of retinal venous occlusionCentral retinal vein occlusionBranch retinal vein occlusionHemi retinal vein occlusionSlide9

Branch Retinal Vein OcclusionThe ophthalmoscopic findings of acute BRVO include :superficial hemorrhages, retinal edema, and often cotton-wool spots (NFL infarcts) in a sector of retina drained by the affected vein . Branch retinal vein occlusions occur most commonly at an arteriovenous crossing.

The degree of macular involvement determines the level of visual impairment.

When the occlusion does not occur at an arteriovenous crossing, the possibility of an underlying retinochoroiditis should be consideredSlide10

The mean age for patients at the time of occurrence is their sixties.The obstructed vein is dilated and tortuous, and, with time, the corresponding artery may become narrowed and sheathed. The quadrant most commonly affected is the superotemporal (63%); nasal vascular occlusions are rarely detected clinically.

A variant of BRVO based on congenital variation in central vein anatomy may involve either the superior half or inferior half of the retina (hemispheric or hemi central retinal vein occlusion

Branch Retinal Vein OcclusionSlide11

Branch Retinal Vein OcclusionThe Eye Disease Case-Control Study identified the following abnormalities as risk factors for the development of BRVO:

. history of systemic arterial hypertension .

cardiovascular disease . increased body mass index at 20 years of age .history of glaucoma.

Diabetes mellitus was not a major independent risk factor.Slide12

Branch Retinal Vein OcclusionHistologic studies suggest that: common adventitia binds the artery and the vein together at the arteriovenous crossing and that thickening of the arterial wall compresses the vein resulting in turbulence of flow, endothelial cell damage, and thrombotic occlusion.Slide13

Branch Retinal Vein OcclusionThe thrombus may extend histologically to the capillary bed. Secondary arterial narrowing often develops in the area of occlusion. Visual prognosis in BRVO is most closely related to the extent of capillary damage and retinal ischemia in the maculaSlide14

Non-perfused BRVOSlide15

Branch Retinal Vein Occlusion. Fluorescein angiography is used to assess the extent and location of retinal capillary nonperfusion. The integrity of the parafoveal capillaries is an important prognostic factor for visual recovery.

Vision may be reduced in acute cases from macular edema, retinal hemorrhage, or perifoveal retinal capillary occlusion.

The hemorrhage resolves over time, and capillary compensation and collateral formation may permit restitution of flow with resolution of the edema and improvement in visual function. In other eyes, however, progressive capillary closure may occur.Slide16

Ischemic BRVO with NeovascularizationSlide17

Branch Retinal Vein OcclusionExtensive retinal ischemia (greater than 5 disc diameters) results in neovascularization from the retina or optic nerve in approximately 40% of eyes, and 60% of such eyes will develop

preretinal bleeding if laser photocoagulation is not performed. Overall, approximately 50%-60% of patients with all types of BRVO will maintain visual acuity of 20/40 or better after 1 year.Slide18

Ischemic BRVO with neovascularizationSlide19

Retinal vasculitis with BRVOSlide20

Retinal Vasculitis with Hemorrhages and Cotton Wool SpotsSlide21

Dilated and tortuous Retinal veins swollen optic disc

intraretinal hemorrhages

Retinal edema

Central retinal vein occlusionSlide22

Type 1 CRVO: A mild, nonischemic form sometimes referred to as partial, perfused, or venous stasis retinopathySlide23

Mild (nonischemic) CRVO is characterized by good visual acuity, a mild afferent pupillary defect, and mild visual field changes. Funduscopy shows mild dilation and tortuosity of all branches of the central retinal vein as well as dot-and-flame hemorrhages in all quadrants of the retina

Nonischemic CRVOSlide24

Nonischemic CRVOMacular edema with decreased visual acuity and mild optic disc swelling may or may not be present. If disc edema is prominent in younger patients, a combined inflammatory and occlusive mechanism may be present that has been termed

papillophlebitis.

Fluorescein angiography usually demonstrates prolongation of the retinal circulation time with breakdown of capillary permeability but minimal areas of nonperfusion.

Anterior segment neovascularization is rare in mild CRVO.Slide25

Fluorescein Angiography

A mild increase in retinal circulation time.

marked delay in arteriovenous transit time, which is longer than 20 seconds, masking by retinal haemorrhages

vessel wall staining.

Late staining along the large retinal veins is a characteristic finding in moderate and severe degrees of central retinal vein obstruction.

Nonischemic CRVOSlide26

Partial Central Retinal Vein Occlusion V Papillophlebitis ODSlide27

Pathophysiology of CRVOHistologic studies suggest that most forms of CRVO have a common mechanism:thrombosis of the central retinal vein at and posterior to the level of the lamina cribrosa.

In some instances, an atherosclerotic central retinal artery may impinge on the central retinal vein, causing turbulence, endothelial damage, and thrombus formation.

central retinal artery and vein share a common adventitial sheath as they exit the optic nerve head and pass through a narrow opening in the lamina cribrosa.Slide28

Type 2: Ischemic CRVOis characterized by at least 10 disc areas of retinal capillary nonperfusion on posterior pole view fluorescein angiography

also known as nonperfused, complete, or

hemorrhagic retinopathySlide29

Ischemic CRVOSlide30

Ischemic CRVO

Ischemic CRVO is characterized by rapid onset venous obstruction resulting in decreased retinal perfusion

severe visual loss

usually less than 20/400

marked afferent pupillary defectSlide31

Ischemic CRVOVariable numbers of cotton-wool spots are frequently found as well The visual prognosis is generally poor in ischemic CRVO, with approximately 10% of eyes achieving vision better than 20/400

The incidence of iris neovascularization is high (up to 60%)Slide32

Ischemic CRVOSlide33

Because of this

narrow entry in the lamina cribrosa

, the vessels are in a tight compartment with

limited space

for displacement. This anatomical position predisposes to thrombus formation in the central retinal vein by various factors:

Ocular compression of the vein:

changes in lamina cribrosa

glaucomatous cupping

inflammatory swelling in optic nerve

orbital compression

Virchow's triad for vascular occlusion

1.Hemodynamic disturbances : hyperdynamic or sluggish circulation

2. Vessel wall changes: vasculitis, endothelial damage, arteriosclerosis

3. Changes in the blood: deficiency of thrombolytic factors, increase in clotting factors

Pathophysiology of CRVOSlide34

Occlusion of the central retinal vein leads to: backup of the blood in the retinal venous system and increased resistance to venous blood flow. stagnation of the blood and

ischemic damage to the retina.

It has been postulated that ischemic damage to the retina stimulates increased production of vascular endothelial growth factor

(VEGF)

in the vitreous cavity. Increased levels of VEGF stimulate neovascularization of the posterior and anterior segment (responsible for secondary complications of CRVO).

It has been shown that VEGF causes capillary leakage leading to macular edema

which is the leading cause of visual loss in both ischemic CRVO and nonischemic CRVO.

Pathophysiology of CRVOSlide35

Pathophysiology of CRVOUnusual diseases that affect clotting mechanisms and blood viscosity may be associated with a CRVO-like picture Examples include:

blood dyscrasias (polycythemia vera), dysproteinemias, and causes of vasculitis (eg, sarcoidosis, systemic lupus erythematosus), and such hypercoagulable conditions as hyperhomocysteinemia, protein S deficiency, and protein C deficiency.

Oral contraceptives and diuretics have been implicated in CRVO.

Slide36
Slide37

IschemiC RVOSlide38
Slide39

CRVO Systemic risk factorsPatients may have premonitory symptoms of transient obscuration of vision prior to overt retinal manifestations. Systemic associations noted in the Eye Disease Case-Control Study include :

systemic arterial hypertension

diabetes mellitus open-angle glaucoma

Increased intraorbital pressure is a

rare but potentially important cause of central vein

hyperlipidemia

?Slide40

Pathophysiology of CRVOhyperviscosity retinopathy can mimic a typical CRVO. However, the retinal findings in hyperviscosity retinopathy are generally bilateral and usually related to dysproteinemia such as Waldenstrom macroglobulinemia or multiple myeloma

Diagnostic testing includes serum protein electrophoresis and measurements of whole blood viscosity.

In many cases, the hyperviscosity can be reversed by plasmapheresis.Slide41

Ischemic CRVOSlide42

Persistent cystoid macular edema in CRVOSlide43

Hemi retinal vein occlusionSlide44

Hyperviscosity retinopathy of high altitudeSlide45

Hyperviscosity retinopathy Slide46

CRVO due to Retinal vasculisSlide47

Toxoplasma Fulminate retinochoroiditisSlide48

Retinal vasculitis due to lupusSlide49

Shaken Baby SyndromeSlide50

Hematological disorders and other systemic conditions

Conditions that lead to increased

blood viscosity

such as

myeloproliferative

disorders are uncommon but known to be associated with CRVO.

Similarly, a number of

rare systemic inflammatory disorders causing systemic

vasculitis

(such as

Behçet’s

disease and

polyarteritis

nodosa

) also cause retinal vasculit

is leading to RVO, especially in the younger age group. The cause and management of the RVO here is closely linked to the underlying systemic disease and its management.

Thrombophilia

refers to the propensity to develop thrombosis (usually venous) due to

an

abnormality in the coagulation system

. This can be congenital (eg, Factor V Leiden, hyperhomocysteinemia or protein C, protein S and

antithrombin

deficiencies) or

acquired (eg, antiphospholipid syndrome), and its importance is potentially greater in the younger age group.

However

Fegan’s

review on CRVO and thrombophilia

14

suggested that there was a lack of consistency between studies in showing a valid association between CRVO and protein C, protein S and

antithrombin

III deficiency, and factor V Leiden/activated protein C resistance

.

In the antiphospholipid syndrome (APS) antibodies to

phospholipid

activate the coagulation cascade leading to both arterial and venous thrombosis.

Tests can be done to either detect the antibody (using the

anticardiolipin

antibody assay) or its effect on coagulation using a test for lupus anticoagulant. Up to 8% of patients with APS have ocular manifestations and

4 of 8 studies reviewed by Fegan

14

showed a significant association of APS in CRVO.

Further studies are required to determine the strength of association between APS and RVO.

Homocysteine

is a naturally occurring amino acid not found in protein. There are many causes for

hyperhomo-cysteinemia

(including rare enzyme deficiencies leading to

homocystinuria

) which predisposes to both arterial and venous thrombosis.

14

Several studies have questioned the validity of carrying out exhaustive tests for

thrombophilia

in RVO in the absence of a suggestive medical history. However their results have shown notable evidence of an association of hyperhomocysteinemia with CRVO sufficient to recommend the benefit of checking for hyperhomocysteinemia, which is correctable with folic acid and vitamins B6 and B12 supplements.

14

17

On current evidence it would be reasonable to not recommend general

thrombophilia

screening for all patients with RVO, but to reserve it for older patients with a past history of

thromboembolic

events and in young patients without any other general risk factors.Slide51

ConclusionThe Exact mechanism is nor knownSystemic:1. Vessel wall2. Hemodynamic3. Blood

Ocular:GlaucomaAnatomicalSlide52

Hyperviscosity retinopathy

- Retina Image Bank

imagebank.asrs.org

Image Search

Search Box

Search query

Slide53
Slide54
Slide55

Types 3 CRVOAn intermediate form also exists, but more than 80% of these eye progress to the severe ischemic form.Slide56
Slide57

Pathophysiology of RVO

Thrombosis within a retinal vein as described earlier will lead to a partial obstruction of blood flow within the vein and from the eye. The subsequent increased

intraluminal

pressure, if sufficiently high, will cause transudation of blood products into the retina according to Starling’s law. This will result in increased interstitial (retinal) fluid and protein. The latter will increase the interstitial

oncotic

pressure which will impede capillary perfusion and lead to ischemia. As stated by

Campochiaro

et al

21

this ischemia is not an all or none dichotomy, as those patients classified as nonischemic will still have varying degrees of retinal ischemia.

It is well recognized that inflammation affects the progression and outcome of

vitreoretinal

disease including retinal vein occlusion.

22

Yoshimura et al

22

have found significantly elevated vitreous levels of the soluble cytokines interleukin (IL) 6 and 8,

monocyte

chemoattractant

protein-1, and vascular endothelial growth factor (VEGF) in RVO, and especially in CRVO.

Funk et al

23

have also demonstrated

elevated aqueous levels of these same factors in patients with CRVO when compared with control samples. The exact interaction of these factors remains speculative but an understanding of the roles that VEGF fulfils is increasing. It is induced by tissue hypoxia such as retinal ischemia and acts as an

angiogenic

and

vasopermeable

factor on endothelial cell membrane bound receptors with tyrosine

kinase

activity.

24

Ozaki et al

25

have demonstrated that the

implantation of slow release pellets of human recombinant VEGF into the vitreous cavity of rabbits and primates leads to retinal vessel dilatation, breakdown of the blood retinal barrier and retinal new vessel formation.

Noma

et al have reported elevated aqueous and vitreous levels of VEGF and IL-6 in patients with BRVO

26

,

27

and CRVO,

28

,

29

compared to controls. The levels of VEGF and IL-6 correlated with both the severity of macular edema and extent of retinal ischemia (capillary nonperfusion).

It is likely that the sudden retinal ischemia that occurs in BRVO and more so in CRVO will induce excessive VEGF production. VEGF is produced by the retina from retinal pigment epithelial cells, endothelial cells, and Muller cells, as well as other types of ocular tissue.

22

Boyd et al found a

close correlation between aqueous VEGF levels and the course of iris neovascularization and vascular permeability in patients with ischemic CRVO.

30

The excessive vascular permeability induced by VEGF will likely contribute to the macular edema that also occurs according to Starling’s law as described above. It is tempting to theorize that even if the primary venous obstruction was overcome (eg, via collateral formation), the macular edema can persist for much longer due to a self perpetuating cycle of VEGF-induced vascular permeability leading to macular edema, capillary damage, and retinal ischemia, stimulating further release of VEGF and other inflammatory cytokines leading to chronic macula edema.Slide58
Slide59
Slide60
Slide61
Slide62
Slide63
Slide64
Slide65
Slide66
Slide67
Slide68
Slide69
Slide70
Slide71

ccacSlide72
Slide73

Fundus autofluorescence can detect, in patients with recent-onset CRVO, a perivenular hypoautofluorescence with a fern-like appearance. Slide74
Slide75
Slide76
Slide77
Slide78
Slide79
Slide80

Retinal Vasculitis due to Lupus

Systemic Lupus Erythematosis

- Vasculitis